Prestige 2 Horse Vaccine

Combination of inactivated, concentrated, adjuvanted, tissue culture origin equine herpesviruses types 1 and 4 (EHV-1 and EHV-4) and equine influenza virus type H3N8 strains EIV A/eq/Florida/RW/13, EIV A/Equine 2/Kentucky/02 American, EIV A/eq/Richmond/1/07.

For the vaccination of healthy horses 6 months of age or older against EIV, EHV-1 and EHV-4. Duration of immunity has been shown at 6 months for EIV. Has been shown to decrease virus shedding of EIV and EHV-1. Foals nursing immune-dams should be vaccinated when maternal antibody levels will allow active immunization.

Dosage: 1 ml IM, repeat in 3-4 weeks. Revaccinate annually.

Anaphylactoid reactions may occur. Antidote: Epinephrine.

U.S. Lic. No. 165A.